Loading...

Susan Lee

TitleTeacher
InstitutionUniversity of California San Diego
Address9500 Gilman Drive #0943
La Jolla CA 92093
Phone858-642-3247
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Case Western Reserve UniversityMD1997Medicine

    Collapse Overview 

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bharti B, Lee SJ, Lindsay SP, Wingard DL, Jones KL, Lemus H, Chambers CD. Disease Severity and Pregnancy Outcomes in Women with Rheumatoid Arthritis: Results from the Organization of Teratology Information Specialists Autoimmune Diseases in Pregnancy Project. J Rheumatol. 2015 Aug; 42(8):1376-82. PMID: 25877497.
      View in: PubMed
    2. Kavanaugh A, Lee SJ, Curtis JR, Greenberg JD, Kremer JM, Soto L, Etzel CJ, Cox V, Yoshida K, Reed GW, Solomon DH. Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry. Ann Rheum Dis. 2015 Jun; 74(6):1150-5. PMID: 25471471.
      View in: PubMed
    3. Khanna D, Sarkin AJ, Khanna PP, Shieh MM, Kavanaugh AF, Terkeltaub RA, Lee SJ, Singh JA, Hirsch JD. Minimally important differences of the gout impact scale in a randomized controlled trial. Rheumatology (Oxford). 2011 Jul; 50(7):1331-6. PMID: 21372003; PMCID: PMC3307519.
    4. Sarkin AJ, Levack AE, Shieh MM, Kavanaugh AF, Khanna D, Singh JA, Terkeltaub RA, Lee SJ, Hirsch JD. Predictors of doctor-rated and patient-rated gout severity: gout impact scales improve assessment. J Eval Clin Pract. 2010 Dec; 16(6):1244-7. PMID: 20722884.
      View in: PubMed
    5. Lee S, Ballow M. Monoclonal antibodies and fusion proteins and their complications: targeting B cells in autoimmune diseases. J Allergy Clin Immunol. 2010 Apr; 125(4):814-20. PMID: 20371395.
      View in: PubMed
    6. Hirsch JD, Terkeltaub R, Khanna D, Singh J, Sarkin A, Shieh M, Kavanaugh A, Lee SJ. Gout disease-specific quality of life and the association with gout characteristics. Patient Relat Outcome Meas. 2010 Mar 01; 2010:1-8. PMID: 21686040.
      View in: PubMed
    7. Kavanaugh A, Lee SJ, Weng HH, Chon Y, Huang XY, Lin SL. Patient-derived joint counts are a potential alternative for determining Disease Activity Score. J Rheumatol. 2010 May; 37(5):1035-41. PMID: 20156946.
      View in: PubMed
    8. Lee SJ, Chinen J, Kavanaugh A. Immunomodulator therapy: monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins. J Allergy Clin Immunol. 2010 Feb; 125(2 Suppl 2):S314-23. PMID: 20036416.
      View in: PubMed
    9. Lee SJ, Kremer J, Kavanaugh A. Treatment disparity related to race/ethnicity and education in rheumatoid arthritis patients: comment on the article by Constantinescu et al. Arthritis Rheum. 2009 Aug 15; 61(8):1141-2. PMID: 19644891.
      View in: PubMed
    10. Lee SJ, Chang H, Yazici Y, Greenberg JD, Kremer JM, Kavanaugh A. Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study. J Rheumatol. 2009 Aug; 36(8):1611-7. PMID: 19369454.
      View in: PubMed
    11. Lee SJ, Hirsch JD, Terkeltaub R, Khanna D, Singh JA, Sarkin A, Kavanaugh A. Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford). 2009 May; 48(5):582-6. PMID: 19307257; PMCID: PMC2722803.
    12. Hirsch JD, Lee SJ, Terkeltaub R, Khanna D, Singh J, Sarkin A, Harvey J, Kavanaugh A. Evaluation of an instrument assessing influence of Gout on health-related quality of life. J Rheumatol. 2008 Dec; 35(12):2406-14. PMID: 18925685.
      View in: PubMed
    13. Lee SJ, Kavanaugh A, Lenert L. Electronic and computer-generated patient questionnaires in standard care. Best Pract Res Clin Rheumatol. 2007 Aug; 21(4):637-47. PMID: 17678825.
      View in: PubMed
    14. Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, Wu CW, Kavanaugh A. The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol. 2007 Jan; 34(1):123-9. PMID: 17216680.
      View in: PubMed
    15. Lee SJ, Kavanaugh A. Biologic agents in rheumatology: safety considerations. Rheum Dis Clin North Am. 2006 Dec; 32 Suppl 1:3-10. PMID: 17410696.
      View in: PubMed
    16. Lee SJ, Terkeltaub RA. New developments in clinically relevant mechanisms and treatment of hyperuricemia. Curr Rheumatol Rep. 2006 Jun; 8(3):224-30. PMID: 16901081.
      View in: PubMed
    17. Lee SJ, Terkeltaub RA, Kavanaugh A. Recent developments in diet and gout. Curr Opin Rheumatol. 2006 Mar; 18(2):193-8. PMID: 16462528.
      View in: PubMed
    18. Lee SJ, Kavanaugh A. 4. Autoimmunity, vasculitis, and autoantibodies. J Allergy Clin Immunol. 2006 Feb; 117(2 Suppl Mini-Primer):S445-50. PMID: 16455344.
      View in: PubMed
    19. Lee SJ, Lenert L, Weisman S, Kavanaugh A. Factors affecting rheumatoid arthritis patients' decisions to participate in clinical trials. J Rheumatol. 2005 Dec; 32(12):2317-25. PMID: 16331756.
      View in: PubMed
    20. Lee SJ, Kavanaugh A. Adverse reactions to biologic agents: focus on autoimmune disease therapies. J Allergy Clin Immunol. 2005 Oct; 116(4):900-5. PMID: 16210067.
      View in: PubMed
    21. Park JM, Brady H, Ruocco MG, Sun H, Williams D, Lee SJ, Kato T, Richards N, Chan K, Mercurio F, Karin M, Wasserman SA. Targeting of TAK1 by the NF-kappa B protein Relish regulates the JNK-mediated immune response in Drosophila. Genes Dev. 2004 Mar 01; 18(5):584-94. PMID: 15037551; PMCID: PMC374239.
    22. Lee SJ, Yedla P, Kavanaugh A. Secondary immune deficiencies associated with biological therapeutics. Curr Allergy Asthma Rep. 2003 Sep; 3(5):389-95. PMID: 12906774.
      View in: PubMed